Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BrainAurora Medical Technology Limited ( (HK:6681) ) has issued an announcement.
BrainAurora Medical Technology Limited announced that its controlling shareholder, executive director and chairman, Tan Zheng, plans to increase his stake in the company by purchasing shares on the open market over the next six months. Using his own funds, Tan intends to invest up to HKD80 million at a maximum price of HKD7 per share, while ensuring compliance with Hong Kong listing rules and maintaining sufficient public float.
Tan and his concert parties currently hold about 33.83% of BrainAurora’s issued share capital, and the board views the planned purchases as a signal of strong confidence in the group’s long-term development and value. The company also cautioned investors that the plan may not be fully executed due to market conditions and other unforeseen factors, and reminded shareholders to remain mindful of investment risks when trading its shares.
More about BrainAurora Medical Technology Limited
BrainAurora Medical Technology Limited is a Cayman Islands–incorporated company listed in Hong Kong that operates in the medical technology sector. The group focuses on developing and commercialising medical technologies, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 6681.
Average Trading Volume: 23,442,096
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.54B
See more insights into 6681 stock on TipRanks’ Stock Analysis page.